OGTT Glucose Response Curves, Insulin Sensitivity, and β-Cell Function in RISE: Comparison Between Youth and Adults at Randomization and in Response to Interventions to Preserve β-Cell Function
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We examined the glucose response curves (biphasic [BPh], monophasic [MPh], incessant increase [IIn]) during an oral glucose tolerance test (OGTT) and their relationship to insulin sensitivity (IS) and β-cell function (βCF) in youth versus adults with impaired glucose tolerance or recently diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: This was both a cross-sectional and a longitudinal evaluation of participants in the RISE study randomized to metformin alone for 12 months or glargine for 3 months followed by metformin for 9 months. At baseline/randomization, OGTTs (85 youth, 353 adults) were categorized as BPh, MPh, or IIn. The relationship of the glucose response curves to hyperglycemic clamp–measured IS and βCF at baseline and the change in glucose response curves 12 months after randomization were assessed. RESULTS: At randomization, the prevalence of the BPh curve was significantly higher in youth than adults (18.8% vs. 8.2%), with no differences in MPh or IIn. IS did not differ across glucose response curves in youth or adults. However, irrespective of curve type, youth had lower IS than adults (P < 0.05). βCF was lowest in IIn versus MPh and BPh in youth and adults (P < 0.05), yet compared with adults, youth had higher βCF in BPh and MPh (P < 0.005) but not IIn. At month 12, the change in glucose response curves did not differ between youth and adults, and there was no treatment effect. CONCLUSIONS: Despite a twofold higher prevalence of the more favorable BPh curve in youth at randomization, RISE interventions did not result in beneficial changes in glucose response curves in youth compared with adults. Moreover, the typical β-cell hypersecretion in youth was not present in the IIn curve, emphasizing the severity of β-cell dysfunction in youth with this least favorable glucose response curve.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the RISE study found that early intensive insulin therapy did not preserve β-cell function (using gold-standard clamp measurements) in children with obesity and adolescents with impaired glucose tolerance or newly diagnosed type 2 diabetes, 58 and worsening of glycaemia at 12 months occurred more commonly in children and adolescents than in adults (17•8% vs 7•5%).59”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Short-term variability in measures of glycemia and implications for the classification of diabetes
Selvin, E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1545 · Cited by 402
The RISE Consortium, Nadeau, K. J., Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Leschek, E. W., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0787 · Cited by 176 · cited 2×
“edu/web/rise/collaborators) (17), with the primary outcome results published (15,16,18).”
BackgroundSelf-citationThe shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes
Abdul‐Ghani, M. A., Lyssenko, V., Tuomi, T., DeFronzo, R. A., & Groop, L. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1084 · Cited by 139
The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
Hannon, T. S., & Arslanian, S. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12939 · Cited by 137
Self-citationThe RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0556 · Cited by 73
Self-citationHulman, A., Witte, D. R., Vistisen, D., Balkau, B., Dekker, J. M., Herder, C., Hatunic, M., Konrad, T., Færch, K., & Manco, M. (2018) · Diabetes Care · doi:10.2337/dc18-0279 · Cited by 66 · cited 1×
“the 3-year observational follow-up were similar to those at baseline (21).”
Result
Research works printed but not linked: 21
- Kim, 2012, Glucose response curve and type 2 diabetes risk in Latino adolescents, Diabetes Care, 35, 1925, 10.2337/dc11-2476 · DOI · Paper page
- Kim, 2016, The shape of the glucose response curve during an oral glucose tolerance test heralds biomarkers of type 2 diabetes risk in obese youth, Diabetes Care, 39, 1431, 10.2337/dc16-0352 · DOI
- Fuchigami, 1994, Oral glucose tolerance test using a continuous blood sampling technique for analysis of the blood glucose curve, Nihon Ronen Igakkai Zasshi, 31, 518, 10.3143/geriatrics.31.518 · DOI
- Tschritter, 2003, Assessing the shape of the glucose curve during an oral glucose tolerance test, Diabetes Care, 26, 1026, 10.2337/diacare.26.4.1026 · DOI · Paper page
- Cheng, 2019, The shape of the glucose response curve during an oral glucose tolerance test heralds β-cell function in a large Chinese population, BMC Endocr Disord, 19, 119, 10.1186/s12902-019-0446-4 · DOI
- Nolfe, 2012, Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth, Eur J Endocrinol, 166, 107, 10.1530/EJE-11-0827 · DOI
- Arslanian, 2019, The shape of the glucose response curve during an oral glucose tolerance test: forerunner of heightened glycemic failure rates and accelerated decline in β-cell function in TODAY, Diabetes Care, 42, 164, 10.2337/dc18-1122 · DOI
- Tura, 2011, Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance, Am J Physiol Regul Integr Comp Physiol, 300, R941, 10.1152/ajpregu.00650.2010 · DOI
- Bervoets, 2015, The shape of the plasma glucose curve during an oral glucose tolerance test as an indicator of beta cell function and insulin sensitivity in end-pubertal obese girls, Horm Metab Res, 47, 445
- Kanauchi, 2005, Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals, Int J Clin Pract, 59, 427, 10.1111/j.1368-5031.2005.00422.x · DOI
- Trujillo-Arriaga, 2008, Fitting and evaluating the glucose curve during a quasi continuous sampled oral glucose tolerance test, Comput Biol Med, 38, 185, 10.1016/j.compbiomed.2007.09.004 · DOI
- RISE Consortium, 2018, Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp, Diabetes Care, 41, 1696, 10.2337/dc18-0244 · DOI · Paper page
- RISE Consortium, 2018, Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: II. Observations using the oral glucose tolerance test, Diabetes Care, 41, 1707, 10.2337/dc18-0243 · DOI · Paper page
- RISE Consortium, 2019, Effects of treatment of impaired glucose tolerance or recently diagnosed type 2 diabetes with metformin alone or in combination with insulin glargine on β-cell function: comparison of responses in youth and adults, Diabetes, 68, 1670
- RISE Consortium, 2014, Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span, Diabetes Care, 37, 780, 10.2337/dc13-1879 · DOI · Paper page
- Arslanian, 2018, Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: who is worse off, Pediatr Diabetes, 19, 205, 10.1111/pedi.12562 · DOI
- Tricò, 2018, Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents, JCI Insight, 3, e124912, 10.1172/jci.insight.124912 · DOI · Paper page
- Manco, 2017, Shape of the OGTT glucose curve and risk of impaired glucose metabolism in the EGIR-RISC cohort, Metabolism, 70, 42, 10.1016/j.metabol.2017.02.007 · DOI
- Dalgård, 2020, Heritability of curve patterns in oral glucose tolerance test, Twin Res Hum Genet, 23, 39, 10.1017/thg.2020.3 · DOI
- Libman, 2008, Reproducibility of the oral glucose tolerance test in overweight children, J Clin Endocrinol Metab, 93, 4231, 10.1210/jc.2008-0801 · DOI · Paper page
- Kramer, 2014, Emerging parameters of the insulin and glucose response on the oral glucose tolerance test: reproducibility and implications for glucose homeostasis in individuals with and without diabetes, Diabetes Res Clin Pract, 105, 88, 10.1016/j.diabres.2014.04.023 · DOI
Cited by
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications
Manfredo, J., Lin, T., Gupta, R., Abiola, K., West, M., Busin, K., Tracey, J., Brown, E. A., Magge, S. N., & Wolf, R. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1182260 · Cited by 25
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0561 · Cited by 11
Overview of Pediatric Obesity as a Disease
Waldrop, S. W., Ibrahim, A. A., Maya, J., Monthe-Dreze, C., & Stanford, F. C. (2024) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2024.06.003 · Cited by 6
Metadata
- Authors
- Arslanian, S. A., El ghormli, L., Kim, J. Y., Tjaden, A. H., Barengolts, E., Caprio, S., Hannon, T. S., Mather, K. J., Nadeau, K. J., Utzschneider, K. M., Kahn, S. E., RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., Atkinson, K. M., Palmer, J. P., Utzschneider, K. M., Gebremedhin, T., Kernan-Schloss, A., Kozedub, A., Montgomery, B. K., Morse, E. J., Mather, K. J., Garrett, T., Hannon, T. S., Lteif, A., Patel, A., Chisholm, R., Moore, K., Pirics, V., Pratt, L., Nadeau, K. J., Gross, S., Zeitler, P. S., Williams, J., Green, M.-C., Garcia Reyes, Y., Vissat, K., Arslanian, S. A., Brown, K., Guerra, N., Porter, K., Caprio, S., Savoye, M., Pierpont, B., Buchanan, T. A., Xiang, A. H., Trigo, E., Beale, E., Hendee, F. N., Katkhouda, N., Nayak, K., Martinez, M., Montgomery, C., Wang, X., Edelstein, S. L., Lachin, J. M., Hogan, A. N., Marcovina, S., Harting, J., Albers, J., Hill, D., Savage, P. J., & Leschek, E. W.
- Affiliations
- George Washington University Biostatistics Center (RISE Coordinating Center), Rockville, MD
- Department of Exercise Science, Syracuse University, Syracuse, NY
- ORCID
- El ghormli, Laure
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-01-12
- Volume
- 44
- Issue
- 3
- Pages
- 817-825
- ISSN
- 0149-5992
- 1935-5548
- Cited by
- 45
- References
- 6
- Language
- en
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-094406, U01-DK-094430, U01-DK-094431, U01-DK-094438, U01-DK-094467)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.